Marc F. Pelletier

Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH.

Gardiner Healthcare Acquisitions Corp. is a blank check company, which engages in merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination. The company was founded on March 25, 2021 and is headquartered in Shaker Heights, OH.

Iridia, Inc. operates as a biotechnology company. It offers research and development services. The company was founded by James P. Linton in 2016 and is headquartered in Carlsbad, CA.